Neonatal Hearing Screening—Short Review
Romanian Journal of Preventive Medicine · 2023
DOI: 10.3390/rjpm2020031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Preventive Medicine, 2023. Verfasst von Andreea Calomfirescu-Avramescu und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Newborn hearing screening is the best strategy to identify congenital deafness and hearing loss. The incidence of sensorineural hearing loss is 3 per 1000 for term newborns and up to 4 per 100 for newborns hospitalized in the NICU, therefore identification up to a maximum of 6 months has an optimal effect on neurocognitive development. Auditory testing techniques have evolved since the 1800s and currently include transient evoked otoacoustic emissions (TEOAE), distortion product otoacoustic emissions (DPOAE), the automated auditory brainstem response (ABR) or a combination of them. In our country we use auditory brainstem response (ABR) and otoacoustic emissions (OAE), thus we can identify up to 85% of hearing loss in the first 6 months of life.
Zitieren
APA
Calomfirescu-Avramescu, A., & Dima, V. (2023). Neonatal Hearing Screening—Short Review. Romanian Journal of Preventive Medicine. https://doi.org/10.3390/rjpm2020031
Vancouver
Calomfirescu-Avramescu A, Dima V. Neonatal Hearing Screening—Short Review. Romanian Journal of Preventive Medicine. 2023. doi:10.3390/rjpm2020031
BibTeX
@article{CalomfirescuAvramescu2023,
author = {Calomfirescu-Avramescu, Andreea and Dima, Vlad},
title = {Neonatal Hearing Screening—Short Review},
journal = {Romanian Journal of Preventive Medicine},
year = {2023},
doi = {10.3390/rjpm2020031}
}
EUVIMED